Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor
Clinical trial NCT05436990 · TERMINATED
Trial details
- NCT number
- NCT05436990
- Sponsor
- Yonsei University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2025-03-10
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.